CA3028031C - Microbial carotenoids affecting gut microbial composition - Google Patents

Microbial carotenoids affecting gut microbial composition Download PDF

Info

Publication number
CA3028031C
CA3028031C CA3028031A CA3028031A CA3028031C CA 3028031 C CA3028031 C CA 3028031C CA 3028031 A CA3028031 A CA 3028031A CA 3028031 A CA3028031 A CA 3028031A CA 3028031 C CA3028031 C CA 3028031C
Authority
CA
Canada
Prior art keywords
microbial
formula
gut
composition
carotenoid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3028031A
Other languages
English (en)
French (fr)
Other versions
CA3028031A1 (en
Inventor
Sam Possemiers
Cindy DUYSBURGH
Iris PINHEIRO
Selin BOLCA
Pieter Van Den Abbeele
Massimo Marzorati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Resource Management Health NV MRM Health
Original Assignee
Microbial Resource Management Health NV MRM Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Resource Management Health NV MRM Health filed Critical Microbial Resource Management Health NV MRM Health
Publication of CA3028031A1 publication Critical patent/CA3028031A1/en
Application granted granted Critical
Publication of CA3028031C publication Critical patent/CA3028031C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA3028031A 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition Active CA3028031C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175832.1 2016-06-22
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (2)

Publication Number Publication Date
CA3028031A1 CA3028031A1 (en) 2017-12-28
CA3028031C true CA3028031C (en) 2023-02-28

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3028031A Active CA3028031C (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Country Status (12)

Country Link
US (1) US11324717B2 (enExample)
EP (1) EP3474862B1 (enExample)
JP (1) JP6966543B2 (enExample)
KR (1) KR102413408B1 (enExample)
CN (1) CN109641006B (enExample)
AU (1) AU2017281589B2 (enExample)
BR (1) BR112018076485A8 (enExample)
CA (1) CA3028031C (enExample)
IL (1) IL263683B (enExample)
MX (1) MX390386B (enExample)
RU (1) RU2759600C2 (enExample)
WO (1) WO2017220708A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
KR20190127710A (ko) * 2017-02-07 2019-11-13 캘리포니아 인스티튜트 오브 테크놀로지 헌팅톤병 및 레트 증후군에서의 장 미생물총의 조정
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
WO2020043797A1 (en) * 2018-08-29 2020-03-05 Dsm Ip Assets B.V. Formulations for improving gut health
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
WO2025262090A1 (en) 2024-06-18 2025-12-26 Dsm Ip Assets B.V. Combination of carotenoids and inulin and uses thereof
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
GB0524873D0 (en) * 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
GB201013041D0 (en) 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids

Also Published As

Publication number Publication date
RU2019101481A3 (enExample) 2020-10-16
BR112018076485A2 (pt) 2019-04-09
JP2019524877A (ja) 2019-09-05
IL263683B (en) 2022-04-01
KR20190039687A (ko) 2019-04-15
US20190209516A1 (en) 2019-07-11
US11324717B2 (en) 2022-05-10
KR102413408B1 (ko) 2022-06-27
RU2759600C2 (ru) 2021-11-16
BR112018076485A8 (pt) 2022-12-06
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
JP6966543B2 (ja) 2021-11-17
RU2019101481A (ru) 2020-07-22
CN109641006A (zh) 2019-04-16
EP3474862A1 (en) 2019-05-01
CN109641006B (zh) 2022-07-01
AU2017281589A1 (en) 2019-01-31
CA3028031A1 (en) 2017-12-28
MX390386B (es) 2025-03-20
EP3474862B1 (en) 2025-10-29
AU2017281589B2 (en) 2023-03-23
IL263683A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
AU2017281589B2 (en) Microbial carotenoids affecting gut microbial composition
Leonard et al. Hydroxycinnamic acids on gut microbiota and health
Simó et al. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development
Shang et al. In vitro and in vivo antioxidant activities of inulin
Klinder et al. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination
Abbasi et al. Postbiotics: science, technology and applications
Faghfoori et al. Cellular and molecular mechanisms of probiotics effects on colorectal cancer
Dias et al. Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis
US11260087B2 (en) Composition for preventing or treating menopause, containing Lactobacillus acidophilus
US12016890B2 (en) Composition for preventing or treating menopause, containing Lactobacillus intestinalis
Bernabeu et al. The potential modulation of gut microbiota and oxidative stress by dietary carotenoid pigments
Cheng et al. Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics
Gulzar et al. Therapeutic Potential of
Odun-Ayo et al. The effect of modified citrus pectin-probiotic on faecal lactobacilli in Balb/c mice
Alu’datt et al. Fermented food-derived bioactive compounds with anticarcinogenic properties: Fermented royal jelly as a novel source for compounds with health benefits
CN121846076A (zh) 用于在微生物组中生产植物营养素的方法和组合物
Li et al. Dietary pectin attenuates Salmonella typhimurium-induced colitis by modulating the TLR2-NF-κB pathway and intestinal microbiota in mice
Park et al. Combining 2′-fucosyllactose and galacto-oligosaccharides exerts anti-inflammatory effects and promotes gut health
Han et al. Postbiotics ameliorate DSS-induced colitis in mice by regulating gut microbiota, promoting tryptophan metabolism, and activating AhR/IL-22 signaling pathway
Samanta Prospective role of prebiotics and probiotics in gut immunity
da FONSECA et al. The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review.
Borgonovi Biocompostos de buriti e maracujá: perfil, aplicação em leite fermentado probiótico e modulação da microbiota in vitro
Minuto From youth to old age: therapeutic potential of microbiota interventions in the gut-brain-axis
CN120417918A (zh) 组合物
WO2025262090A1 (en) Combination of carotenoids and inulin and uses thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200608

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250613

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250613

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260804